Law and Admin Flashcards

1
Q

What are the MRA approved countries list for batch importation?

A

Isreal
Australia
Swi
NZ
Can
JP US
EU/EEA

Certain restrictions for ATMPs, Blood products, Medicinal gasses, Homeopathics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

When do you need MIA? When do you need WDA?

A

MIA- Manufacture and importation licence- allows manufacture, import and distribution for products made at that site.
WDA- when you import and distribute products from other sites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the role of PIC/s?

A

Pharmaceutical inspection co-operation scheme.

Set standards for inspectorates globally, train auditors from national authorities and provide audit guidance (aid memoirs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

You need to recall material. What actions do you need to take?

A

May be prior to root cause
Understand where the batches are
Determine how far into supply chain you recall to
Inform all competent authorities
Market specific recall actions
Secure storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are API importation controls?

A

New MA or variation requires API QP declaration approval

If 3rd country and not approved for active substance manufacture to UK GMP, needs to have national competent authority approval from country of manufacture

GDP guidance 2015/c95/01
EUFMD 2011/62/EC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What controls measures are in place for excipients?

A

Guidance present in Eudralex vol 4 section 3 - excipients RA.
-2015/c95/02 GDP guidance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is present in the non- clinical module of the CTD?

A

Toxicology information
Interactions
ADR
Carcinogenicity
Sensitisation
Max dose in animals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are responsibilities of QPPV

A

Monitor market reported ADRs
Create and maintain effectiveness of PV system
Prepare PV reports
Respond to HA requests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What types of licenses are available?

A

MIA
WDA
MIA IMP
Specials Licence
Veterinary Licence

API registration
Broker registration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is contained in manufacturing licence?

A

Authorisation number
Name of holder
Address
Legal basis (SI)
Date of authorisation
Scope of authorisation
- Sterile
-Non-sterile
- Packaging
-QC
-Imported goods
Named QPs + Heads of manufacture and QC.
Contract labs for release testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is contained in site master file?

A

Guidance document in part 3 eudralex volume 4
1. General information on the manufacturer
2. PQS elements
3. Personnel
4. Premises and equipment
5. Documentation
6. Production activities on site
7. QC
8. Distribution/ complaints and recall
9. Self inspection
Appendixes
- Copy of site licence
- Copy of GMP certificate
- Contract manufacturers and QC labs
- Key personnel
- Key equipment
- Water systems
- Plant layouts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is in the CTD and where do you find guidance on this?

A

Common technical document- contains;
Module1- Regional information
Module 2- Quality, non clinical summary/overview, clinical summary/overview
Module 3- Quality module
Module 4- Non clinical study reports
Module 5- Clinical study reports

Format found in ICH M4 and M8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is contained in the Quality module of the CTD?

A

P.3.2S- Drug substance
-General Information
-Characterisation
-Manufacture
-Control of DS
-Stability
-Container closure
-Reference standards

P.3.2P Drug product
-Description and composition
-Pharm Dev
-Manufacturing process and controls
-Excipient control
-Control of DP
-Reference standards
-Stability
-Container closure system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the routes of MA application in the EU? Who reviews them?

A

National procedure- One country
Mutual recognition procedure- MA in one country and others recognise
Decentralised- Apply to one reference country and many others at same time
Centralised- through EMA, EU wide application

CHMP and CVMP review applications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the MA application routes for the UK? What licences do the MHRA currently issue?

A

National procedure
Reliance procedure (IRP)
Innovative licencing and access pathway

PLUk PLNI, PLGB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What do you know about IRP?

A

International recognition procedure
Approval in a listed country means a streamline review of the MA for the UK (reliance procedure).

Countries are;
EU/EEA
Japan
USA
Canada
Singapore
Switzerland
Australia

17
Q

What is the structure of the PhEur? Where is legal basis of EU and BP?

A

General notices- Basic understanding
General chapters- General methods, analytical methods
General monographs- Dosage forms, groups of products
Individual monographs- Mandatory quality aspects

EU- 2001/83/EC
UK- 2012/1916

18
Q

What is the structure of a monograph? Who issues them?

A

Description
Production
Characteristics
ID
Test/assay
Storage
Labelling

EDQM issue monographs- council of Europe.

BP commission- prepares and publishes the BP.

19
Q

What do you know about CEPs?

How long are they valid for?

A

Certificate of suitability to PhEur issued by EDQM.

Covers substances defined in monographs
Covers products at risk of TSE
Quality of the final material can be controlled by using the monograph
Not a GMP certificate- doesn’t qualify quality of manufacture.

Valid for 5 years.

20
Q

What is the organisation of the MHRA?

A

UK department of health
Located in canary wharf
Executive team and Agency board

Science and innovation
Healthcare quality and access
Safety and Surveillance

Within healthcare quality and access;
-Devices
-Medicines
-Authorisation lifecycle
-Population health
-Standards and compliance
>Compliance teams, GLP,GDP, GMP

21
Q

What is the role of EMA?

A

European medicines agency
-Co-ordinate resources of member states
-Support with scientific advice (NPI)
-Maintain Eudravigillence and EudraGMP databases
- Co-ordinate inspection responses.

22
Q

What is the role of the DMRC?

A

Defective medicines reporting centre

Assess impact of defective medicines to public health

Ensure medicines availability and safety

Respond to yellow cards (Sentinel system)

23
Q

How does the reporting of defective veterinary medicines work?

A

VMD defect reporting
Rapid alert notification
Defect report form on website
Recall class 1,2,3
Yellow card system

24
Q

What is the role of the VMD?

A

Veterinary medicines directorate
Part of DEFRA
Links to MHRA and Health department
Review licence applications
Co-ordinate inspection programme
Co-ordinates yellow card reporting system.

25
Q

What is the role of CHMP and CVMP?

A

Committee for medicinal products for human use;
- Assess new MA applications
-Assess variations to MAs
- Review safety assessments
-Power to change, suspend or revoke MAs

Committee for veterinary products for animal use. As above for vet products.

26
Q

Describe the MHRA recall classifications

A

Class 1
- National patient safety alert
- Risk of death or disability
- Immediate recall initiation
- Patient level
Class 2
- Mistreatment or harm to patients
-Not life threatening
- 48 hours to recall
- Pharmacy and wholesale
Class 3
- Defect unlikely to cause harm
- MA non compliance, specification non compliance.
- 5 days
-Pharmacy and wholesale
Class 4
- Caution in use notice
- No threat, minor packaging defect
- Also used when supply constraints do not support recall.

27
Q

What is the legal basis for Pharmacovigilance and where is further guidance? How would you describe PV?

A

2001/83/EC
Regulation 726/2004
2012/1916
Eudralex volume 9

Safety profile of the drug in use
Monitoring for previously unseen ADRs.

28
Q

What are the responsibilities of the QPPV?

A

Legal basis in 2001/83 and 2012/1916

MA holder shall have permanent and continuous availability of appropriately qualified QPPV

Responsibilities;
Establish and maintain PV system
Prepare PV reports
Support HA questions and provide safety information.

29
Q

What are the PV requirements of the MA holder?

A

Prepare periodic safety update reports
Prepare individual case study reports
Prepare and maintain PV master file

30
Q

What is the adverse event process for veterinary products and for human IMP products?

What is required in the event of an IMP PV issue?

A

Vet- Suspect adverse reaction surveillance
IMP- Suspect Unexpected Severe Adverse Report

IMP SUSAR- Report to competent member state and ethics board.

31
Q

What is currently in place for NI supply of medicines from GB?

A

Bridging regulation 2022/642

GB can export GB tested ad QP certified material to NI…..IF….
- Meets full EU law within MA
- Can’t legally be sold in EU
- Scanning a pack in EU leads to error code on EMVO.

32
Q

What will change in 2025 for GB supply to NI?

A

Windsor framework
-January 1st 2025 the MHRA will issue UK wide product licences inclusive of NI
-Packs of product authorised across UK
- No longer require security features
-Labelled/Artwork as ‘For UK Only’
-6M stickering allowed before artwork updated.

33
Q

What is required to be in place for EU supply of products to UK?

A

No import testing requirements
QP cert in EU
Verification of QP cert in UK by responsible person
RP is responsible for system used to verify EU QP cert
GB warehouse must have WDA

34
Q

What was Brexit amendment to CT SI 2004/1031 in the UK?

A

SI 2019/744

35
Q

What are the different legislations controlling medicines in the UK?

A

2012/1916- Human medicines regulation

2004/1031- clinical trials for human use

2013/2033- Veterinary medicines

2003/1680- Specials for human use